Your browser doesn't support javascript.
loading
Safety and efficacy of autologous hematopoietic stem-cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis.
Mariottini, A; Innocenti, C; Forci, B; Magnani, E; Mechi, C; Barilaro, A; Nistri, R; Fani, A; Saccardi, R; Massacesi, L; Repice, A M.
Affiliation
  • Mariottini A; Department of Neurosciences Drug and Child Health, University of Florence, Florence.
  • Innocenti C; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence.
  • Forci B; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy.
  • Magnani E; Department of Neurosciences Drug and Child Health, University of Florence, Florence.
  • Mechi C; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence.
  • Barilaro A; Department of Neurosciences Drug and Child Health, University of Florence, Florence.
  • Nistri R; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence.
  • Fani A; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence.
  • Saccardi R; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence.
  • Massacesi L; Department of Neurosciences Drug and Child Health, University of Florence, Florence.
  • Repice AM; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy.
Eur J Neurol ; 26(4): 624-630, 2019 04.
Article de En | MEDLINE | ID: mdl-30414315
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transplantation de cellules souches hématopoïétiques / Sclérose en plaques récurrente-rémittente / Natalizumab / Immunosuppresseurs Type d'étude: Observational_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: Eur J Neurol Sujet du journal: NEUROLOGIA Année: 2019 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transplantation de cellules souches hématopoïétiques / Sclérose en plaques récurrente-rémittente / Natalizumab / Immunosuppresseurs Type d'étude: Observational_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: Eur J Neurol Sujet du journal: NEUROLOGIA Année: 2019 Type de document: Article